SEC Comment Letter for UNITEDHEALTH GROUP INC (UNH) (CIK 0000731766) (UNH) — Apr 25, 2012
UNITEDHEALTH GROUP INC (UNH) (CIK 0000731766)
Date: April 25, 2012 · CIK: 0000731766 · Accession: 0000000000-12-021332
AI Filing Summary & Sentiment
File numbers found in text: 001-10864
Show Raw Text
April 25, 2012 Via E-mail David S. Wichmann Executive Vice President, And Chief Financial Officer UnitedHealth Group Incorporated UnitedHealth Group Center 9900 Bren Road East Minnetonka, Minnesota 55343 Re: UnitedHealth Group Incorporated Form 10-K for the Fiscal Year Ended December 31, 2011 Filed February 9, 2012 File No. 001-10864 Dear Mr. Wichmann: We have limited our review to only your fina ncial statements and related disclosures and do not intend to expand our review to other porti ons of your document. In our comments, we ask you to provide us with information so we may better understa nd your disclosure. Please respond to this letter within 10 business days by providing the requested information or by advising us when you will provide the requested response. If you do not believe a comment applies to your facts and circ umstances, please tell us why in your response. Please furnish us a letter on EDGAR under the fo rm type label CORRESP that keys your responses to our comment. After reviewing the information provided, we may have additional comments and/or request that you amend your filing. Item 7. Management’s Discussion And Analys is Of Financial Cond ition And Results Of Operations Critical Accounting Estimates Revenues, page 46 1. You state that effective in 2011, premium revenue subject to the premium rebates of the Health Reform Legislation are recognized based on the estimated premium earned net of the projected rebates over the period of the contract, when that amount can be reasonably estimated and that the estimated premium is revised each period to reflect current experience. Please address the following: 5 David S. Wichmann UnitedHealth Group Incorporated April 25, 2012 Page 2 Provide us proposed disclosure to be included herein in fu ture periodic reports that discloses the amount of these rebates recorded to revenue and any material changes in the prior period estimate. Please clarify what amount you are referring to in your st atement “when that amount can be reasonably estimated”. If you ar e not recording reba tes that cannot be reasonably estimated please tell us why this is appropriate. Provide us proposed disclosure to be included in your fina ncial statements of future periodic reports describing how you determ ine the amount of these rebates and your accounting policy for recording them. Consolidated Financial Statements Notes to Consolidated Financial Statements 12. Commitments and Contingencies, page 81 2. You state that you provide guara ntees related to your perfor mance under certain contracts and that, if standards are not me t, you may be financially at ri sk up to a stated percentage of the contracted fee or a stated dol lar amount. Please tell us the following: Your accounting policy for recording these gua rantees and an analysis demonstrating how it complies with GAAP; The contracts that these guarantees relate and your revenue recognition policy for fees under these contracts specifica lly addressing how the fees are fixed or determinable as discussed in Staff Accounting Bulletin Topic 13.A.4. Revenue Recognition; and For each of the last three years, the porti on of your fees subject to guarantees and the maximum amount that is at risk. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing include s the information the Securities Exchange Act of 1934 and all applicable Exchange Act rules requir e. Since the company and its management are in possession of all facts relating to a company’s disclosure, they are responsible for the accuracy and adequacy of the disclosures they have made. In responding to our comments, please provi de a written statement from the company acknowledging that: the company is responsible for the adequacy an d accuracy of the disclo sure in the filing; staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federa l securities laws of the United States. 5 David S. Wichmann UnitedHealth Group Incorporated April 25, 2012 Page 3 Please contact James Peklenk, Staff Account ant, at (202) 551-3661 or Joel Parker, Accounting Branch Chief, at (202) 551-3651, if you have any questions regarding the comments. In this regard, do not hes itate to contact me at (202) 551-3679. Sincerely, /s/ Jim B. Rosenberg Jim B. Rosenberg Senior Assistant Chief Accountant